Evaluatieagenda Oncologie
-
Low dose cisplatin weekly versus high dose cisplatin every three weeks with radiotherapy in sarcopenic head and neck cancer patients
-
Pharmacokinetic boosting of olaparib to improve exposure, tolerance and cost-effectiveness (PROACTIVE)
-
Patient guided dose reduction strategy of Tyrosine Kinase Inhibitors in chronic myeloid leukemia: rodeo study
-
Towards patient-led follow-up after curative treatment of stage II and III colorectal cancer
-
Multi-institutional Evaluation of the Cost-effectiveness of PSMA-PET/CT for the Detection of Pelvic Lymph Node Invasion in Newly Diagnosed Prostate Cancer Patients (PSMA-SELECT)
-
Evaluation of nationwide long-term follow-up care for lymphoma survivors in the Netherlands: does survivorship care at the BETER clinics reduce morbidity and mortality from late effects of lymphoma treatment and associated costs?
-
NABOR
-
PREPARATION
-
RECOVER
-
TailoRing anti-androgEn therapy For metastatic castration resistant prostate cancer based on early tumor response markers In combiNation with drug Exposure measurement (REFINE-project)
-
Clinical impact of dedicated MR staging of ovarian cancer patients
-
GERiatric Screening in the treatment of elderly patients with Ovarian Carcinoma (GERSOC)
-
MR Proper: Risk assessment and MR imaging in prostate cancer diagnosis: an impact analysis
-
The (cost)effectiveness of neoadjuvant FOLFIRINOX versus upfront surgery for (borderline) resectable pancreatic cancer.
-
Individualized PeMetRexed dOsing in lung cancER and mesothelioma patients to improVE treatment response and allow treatment of patients with impaired renal function – The IMPROVE study (previous acronym: PROPER study).
-
Pharmacokinetic boosting of osimertinib in patients with non-small cell lung cancer using cobicistat
-
DA VINCY trial: optimal Duration of Aprepitant therapy for nausea and Vomiting INduced by ChEmotherapY in children: a double-blind placebo-controlled crossover randomized phase III trial
-
SONIA - Endocrine therapy plus CDK 4/6 inhibition in first or second line for hormone receptor positive advanced breast cancer
-
Improving the quality of life of patients with breast cancer-related lymphedema by lymphaticovenous anastomosis (LVA): A randomized controlled trial.
-
The TRIASSIC study: Multicentre, randomised controlled trial comparing TRansanal minimal InvAsive Surgery (TAMIS) and endoscopic Submucosal dIsseCtion (ESD) for resection of non-pedunculated rectal lesions.
-
Dedicated MR imaging vs surgical staging of peritoneal carcinomatosis in colorectal cancer patients; a randomised multicenter trial.
-
GOLD study: Glioblastoma, Optimizing Logistics and Dose.
Archief
-
Autologe Vettransplantatie (AFT) bij borstreconstructies na borstkanker; de techniek van de toekomst bij borstreconstructies.
-
Rapid Access to Contrast-Enhanced spectral mammogRaphy (RACER): a more efficient work-up of women recalled from breast cancer screening
-
Equally good, with less: Omitting the sentinel node biopsy in clinically node negative early breast cancer patients
-
Adjuvant VACcination against HPV in surgical treatment of ClN-lesions, a Randomized Controlled Trial (VACCIN study)'
-
(Cost)-effectiveness of optical coherence tomography versus regular punch biopsy in the diagnosis and subtyping of basal cell carcinoma: a multi-center randomized non-inferiority trial
-
The (cost-)effectiveness of patient-tailored interdisciplinary Medical Specialist Cancer Rehabilitation compared with usual care in patients with complex adverse effects of cancer or the treatment